Clincosm LogoSign in Get a demo

gastrooesophageal cancer

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

Not yet recruiting
  • Gastrooesophageal Cancer
  • Trastuzumab deruxtecan
  • Southampton, Hampshire, United Kingdom
  • +16 more
Jul 27, 2023

Adenocarcinoma Gastric, Gastrooesophageal Cancer Trial in Worldwide (Ramucirumab (CYRAMZA®), Tusamitamab ravtansine (SAR408701))

Recruiting
  • Adenocarcinoma Gastric
  • Gastrooesophageal Cancer
  • Ramucirumab (CYRAMZA®)
  • Tusamitamab ravtansine (SAR408701)
  • Bruxelles, Belgium
  • +22 more
Jan 16, 2023

Gastrooesophageal Cancer Trial in Sutton (ibrutinib)

Unknown status
  • Gastrooesophageal Cancer
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Trust
Sep 17, 2019

Esophageal, Gastrooesophageal Cancer, Gastric Cancer Trial in Pawtucket, Providence (jevtana)

Terminated
Has Results
  • Esophageal
  • +2 more
  • Pawtucket, Rhode Island
  • +2 more
Apr 10, 2019

HER-2 Positive Gastric Cancer, Gastrooesophageal Cancer, Esophageal Cancer Trial (Afatinib, Paclitaxel)

Withdrawn
  • HER-2 Positive Gastric Cancer
  • +2 more
  • (no location specified)
Mar 10, 2017

Permission to Collect Blood Over Time for Research

Terminated
  • Pancreatic Cancer
  • +13 more
  • Observation
  • Stanford, California
    Stanford University School of Medicine
Jul 6, 2016

Esophageal Cancer, Gastrooesophageal Cancer Trial in Liestal (Esophageal Stump Washout)

Completed
  • Esophageal Cancer
  • Gastrooesophageal Cancer
  • Esophageal Stump Washout
  • Liestal, Basel-Land, Switzerland
    Kantonsspital Baselland, Liestal
Feb 24, 2016

B-Receptor Signaling in Cardiomyopathy

Completed
  • Carcinomas
  • +37 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 16, 2015